SAN DIEGO, March 17, 2026 /PRNewswire/ — VST BIO Corporation (“VST BIO”), a biotechnology company developing stroke therapeutics, announces the closing of its Series A financing, led by Coefficient Giving, a philanthropic funder and advisor that partners with donors on cost-effective,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
